메뉴 건너뛰기




Volumn 261, Issue 9, 2014, Pages 1828-1829

Thyroid papillary carcinoma after alemtuzumab therapy for MS

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 84939895123     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7453-1     Document Type: Letter
Times cited : (11)

References (4)
  • 1
    • 84869492471 scopus 로고    scopus 로고
    • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing–remitting multiple sclerosis: a randomised controlled phase 3 trial
    • COI: 1:CAS:528:DC%2BC38Xhs1ajtbjE, PID: 23122652
    • Cohen JA et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing–remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380(9856):1819–1828
    • (2012) Lancet , vol.380 , Issue.9856 , pp. 1819-1828
    • Cohen, J.A.1
  • 2
    • 64549114616 scopus 로고    scopus 로고
    • Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005
    • PID: 19240234
    • Enewold L et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791
    • (2009) Cancer Epidemiol Biomarkers Prev , vol.18 , Issue.3 , pp. 784-791
    • Enewold, L.1
  • 3
    • 84881464304 scopus 로고    scopus 로고
    • The increasing incidence of thyroid cancer: the influence of access to care
    • PID: 23517343
    • Morris LG et al (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23(7):885–891
    • (2013) Thyroid , vol.23 , Issue.7 , pp. 885-891
    • Morris, L.G.1
  • 4
    • 84902602771 scopus 로고    scopus 로고
    • Low risk papillary thyroid cancer
    • PID: 24935445
    • Brito JP, Hay ID, Morris JC (2014) Low risk papillary thyroid cancer. BMJ 348:g3045
    • (2014) BMJ , vol.348 , pp. g3045
    • Brito, J.P.1    Hay, I.D.2    Morris, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.